Skip to content
healthcare.dev

NAPROXEN SODIUM

NDC 53345-042, Naproxen Sodium, capsule, liquid filled, from Humanwell PuraCap Pharmaceuticals (Wuhan) Co., Ltd.

Product NDC
53345-042
Status
Listed
Labeler
Humanwell PuraCap Pharmaceuticals (Wuhan) Co., Ltd
Dosage form
CAPSULE, LIQUID FILLED
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA208363
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/53345-042 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NAPROXEN SODIUM220 mg/1

Pharmacologic classes

Anti-Inflammatory Agents, Non-Steroidal [CS]; Cyclooxygenase Inhibitors [MoA]; Nonsteroidal Anti-inflammatory Drug [EPC]

Package NDCNDC-11Package
53345-042-01533450042011 BAG in 1 BOX (53345-042-01) / 5000 CAPSULE, LIQUID FILLED in 1 BAG

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 53345-042 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/53345-042 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 53345-042. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.